Funded Biotechnology Startups in Helsinki
Helsinki's biotechnology sector shows consistent deal flow from late 2022 through mid-2025, with nine of the ten most recent rounds carrying disclosed amou…
Helsinki's biotechnology sector shows consistent deal flow from late 2022 through mid-2025, with nine of the ten most recent rounds carrying disclosed amounts. Round sizes span from Solu's $1M pre-seed in June 2023 to Onego Bio's $29M Series A in April 2024, the largest disclosed figure in the set. Three closings occurred in the first five months of 2025: Herantis Pharma ($5M, February), Valo Therapeutics ($21M, March), and Nanoform ($6M, June 19).
Four rounds in the cohort carry a Series Unknown classification — Nanoform, Valo Therapeutics, Herantis Pharma, and Nexstim — which limits visibility into round structure even where dollar amounts are disclosed. The remaining six rounds span a range of identified stages: one pre-seed (Solu), three seeds (Resistomap, Measurlabs, and NADMED), one Series A (Onego Bio), and one Series B (Solar Foods at $9M in April 2024).
Most recent rounds
10 shownRelated listings
Frequently asked
What are the largest disclosed rounds among these Helsinki biotech companies?
Onego Bio raised $29M in a Series A closed April 2, 2024 — the largest disclosed amount in the dataset. Valo Therapeutics follows at $21M (March 2025, Series Unknown), then Solar Foods at $9M in a Series B (April 2024). The remaining seven disclosed rounds range from $1M to $6M.
How active has Helsinki biotech fundraising been in 2025?
Three rounds closed in the first five months of 2025: Herantis Pharma ($5M, February 6), Valo Therapeutics ($21M, March 10), and Nanoform ($6M, June 19). All three are classified as Series Unknown, limiting visibility into round structure.
What stages are most of these Helsinki biotech companies raising at?
Four of the ten rounds carry a Series Unknown classification, which partially obscures stage distribution. Among the six with identified stages, three are seeds (Resistomap, Measurlabs, NADMED), one is pre-seed (Solu), one is Series A (Onego Bio), and one is Series B (Solar Foods) — indicating a predominantly early-stage cohort.
Which company closed the most recent round?
Nanoform closed the most recent round in the dataset on June 19, 2025, raising $6M in a Series Unknown round.
Is any round amount information missing from this data?
NADMED's seed round from October 4, 2022 carries no disclosed amount — it is the only entry among the ten most recent rounds without a published figure. All other nine rounds include a dollar value.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.